Clinical Trial Update: A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

Phase IIb randomized trial evaluating AZD9056 in patients with rheumatoid arthritis completed with results posted in October 2010. The study employed a double-b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD9056

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2010-10-04